April 14 to April 20, 2024 The Future Is Lab Every single day, the work of laboratory professionals and pathologists is instrumental in healthcare and the delivery of patient care. Their diagnostic testing, performed in the lab, is a crucial part of the healthcare process. The 49th Annual Lab Week is sponsored by the American […]
PR Newswire Transaction to enhance Labcorp’s laboratory services network and expand access to the company’s high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI, March 28, 2024 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select […]
March is National Colorectal Cancer Awareness Month, a time to come together to raise awareness about the importance of early detection and prevention of colorectal cancer. This month presents an opportunity to promote and market the offerings of BioReference Health in the field of colorectal cancer care. At BioReference, we are dedicated to advancing oncology […]
Clinical testing and genomic insights have revolutionized the way disease is understood, which has enabled personalized treatment approaches that can be tailored to an individual’s unique genetic makeup. Harnessing the potential of genomic testing and its cutting-edge technology can significantly benefit patient outcomes. Read on to learn how BioReference® is supporting genomic testing and clinical […]
February is American Heart Month, a time to raise awareness about heart health and encourage everyone to take steps to prevent heart disease. At BioReference Health®, we are dedicated to supporting heart health and empowering individuals to prioritize their cardiovascular well-being. Through cutting-edge diagnostic testing, personalized wellness offerings, and educational resources, we are honored to […]
As we come together to recognize World Cancer Day in February 2024, it’s important to acknowledge the significant strides being made in cancer care. (123) BioReference continues to be at the forefront of these efforts, demonstrating a steadfast commitment to advancing oncology testing, tailored precision medicine, collaborative care and support, advancements in cancer research, and […]
As we enter January, the month dedicated to raising awareness about cervical cancer, it is crucial to emphasize the significance of early detection and prevention of this prevalent but preventable disease. (1,2,3,4,5) This Cervical Cancer Awareness Month, we are delighted to announce the collaborative efforts of BioReference Health and Teal Health in supporting a groundbreaking […]
In the world of healthcare, data has become essential to driving better patient outcomes. From clinical records to genomic insights, the convergence of various data sources is revolutionizing research and development (R&D) in pharmaceutical companies. In this article, we will explore the remarkable potential of real-world data (RWD), particularly in oncology, and how its integration […]
Elmwood Park, NJ – November 28, 2023 – BioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data (“RWD”) for the pharmaceutical and life science industries. This collaborative arrangement will offer healthcare providers and researchers unique solutions […]
Lung and bronchus cancer represents more than one eighth of all new cancer cases in the US and is the leading cause of cancer deaths worldwide, according to the World Health Organization. As we wrap up on National Lung Cancer Awareness Month this November, we aim to empower patients to take more control of their […]